MY

Mohamed Yasar Arafath

Active Director Director DIN 06824257
DIN 06824257 First appointment Mar 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value •••• Premium profile

About Mohamed Yasar Arafath

Data last updated:

Mohamed Yasar Arafath is a Director at Well Worth Life Sciences Private Limited (since 2014). The company operates in Pharma. Well Worth Life Sciences Private Limited reported revenue of ₹25 Lakh (FY 2024).

DIN 06824257
Primary Designation Director
Industry Pharma
First Appointment 13 Mar 2014
Oldest Company Age 12 yrs
Largest company Well Worth Life Sciences Private Limited · ₹25 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Mar 20142014₹25 Lakh (FY 2024)Active

Board colleagues of Mohamed Yasar Arafath

Directorship timeline

Open interactive timeline →
Well Worth Life Sciences Private Limited
Premium access

Shareholding and investment profile for Mohamed Yasar Arafath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamed Yasar Arafath

Mohamed Yasar Arafath currently holds 1 directorship: Well Worth Life Sciences Private Limited (Director, since 13 Mar 2014, revenue ₹25 Lakh (FY 2024)).

Mohamed Yasar Arafath was first appointed on 13 Mar 2014 as Director at Well Worth Life Sciences Private Limited.

The current boards of Mohamed Yasar Arafath's companies include Anwar Ali Fathima Safrin (Well Worth Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available